Skip to main content

BRIEF-Ampio Pharma Reports Positive Results For Ampion Phase 3 Trial In Severe Osteoarthritis-Of-Knee

* AMPIO PHARMACEUTICALS REPORTS POSITIVE RESULTS FOR BOTH PRIMARY AND SECONDARY ENDPOINTS OF PHASE 3 TRIAL OF AMPION IN SEVERE OSTEOARTHRITIS-OF-KNEE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.